Qiagen (QGEN) Stock Forecast & Price Target

Compare

405 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

QGEN Analyst Ratings

Moderate Buy

8 Buy

7 Hold

0 Sell

Based on 15 analysts giving stock ratings to

Qiagen

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

QGEN Stock 12 Month Forecast

Average Price Target

$52.08

▲(7.69% Upside)

Based on 15 Wall Street analysts offering 12 month price targets for Qiagen in the last 3 months. The average price target is $52.08 with a high forecast of $60.00 and a low forecast of $45.00. The average price target represents a 7.69% change from the last price of $48.36.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"37":"$37","43":"$43","49":"$49","55":"$55","61":"$61"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":60,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$60.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":52.08,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$52.08</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":45,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$45.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[37,43,49,55,61],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,49.94,50.71384615384615,51.487692307692306,52.26153846153846,53.035384615384615,53.809230769230766,54.58307692307692,55.356923076923074,56.13076923076923,56.90461538461538,57.67846153846154,58.45230769230769,59.22615384615385,{"y":60,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,49.94,50.104615384615386,50.26923076923077,50.433846153846154,50.598461538461535,50.76307692307692,50.927692307692304,51.09230769230769,51.25692307692307,51.42153846153846,51.58615384615384,51.75076923076923,51.91538461538461,{"y":52.08,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,49.94,49.559999999999995,49.18,48.8,48.42,48.04,47.66,47.28,46.9,46.519999999999996,46.14,45.76,45.38,{"y":45,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":45.56,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":45.47,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":44.67,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":42.85,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":43.42,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":44.29,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":44.41,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":38.2,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":39.3,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":41.98,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":44.67,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":47.96,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":49.94,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$60.00

Average Price Target$52.08

Lowest Price Target$45.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

TipRanks AITipRanks

Not Ranked

TipRanks

$52

Hold

7.53%

Upside

Downgraded

08/07/25

Qiagen's overall stock score is driven by strong financial performance and positive earnings call outcomes, highlighting robust sales growth and profitability improvements. However, the high P/E ratio suggests potential overvaluation, and technical indicators show mixed signals, with short-term bearish momentum but longer-term positive trends.

Daniel AriasStifel Nicolaus

Stifel Nicolaus

$45

Hold

-6.95%

Downside

Reiterated

08/08/25

Dan LeonardUBS

UBS

$48→$50

Hold

3.39%

Upside

Reiterated

08/07/25

Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (NASDAQ: PRCT), Amgen (NASDAQ: AMGN) and Qiagen (NYSE: QGEN)

Catherine Ramsey SchulteRobert W. Baird

Robert W. Baird

$45→$49

Hold

1.32%

Upside

Reiterated

08/07/25

Robert W. Baird Reaffirms Their Hold Rating on Qiagen (QGEN)

Daniel BrennanTD Cowen

TD Cowen

$49→$52

Hold

7.53%

Upside

Reiterated

08/07/25

TD Cowen Keeps Their Hold Rating on Qiagen (QGEN)

Tycho PetersonJefferies

Jefferies

―

Buy

―

Reiterated

08/07/25

Analysts Conflicted on These Healthcare Names: QuidelOrtho (NASDAQ: QDEL), Qiagen (NYSE: QGEN) and Halozyme (NASDAQ: HALO)

Andrew BrackmannWilliam Blair

William Blair

―

Hold

―

Assigned

08/07/25

Hold Rating on Qiagen Amidst Strong Performance and Market Uncertainties

Luke SergottBarclays

Barclays

$55

Buy

13.73%

Upside

Reiterated

08/07/25

Barclays Sticks to Their Buy Rating for Qiagen (QGEN)

Casey WoodringJ.P. Morgan

J.P. Morgan

$60

Buy

24.07%

Upside

Reiterated

08/06/25

J.P. Morgan Remains a Buy on Qiagen (QGEN)

Jan KochDeutsche Bank

Deutsche Bank

―

Buy

―

Reiterated

08/06/25

Qiagen (QGEN) Gets a Buy from Deutsche Bank

Harry GillisBerenberg Bank

Berenberg Bank

$58.29

Buy

20.54%

Upside

Reiterated

07/31/25

Qiagen (QGEN) Gets a Buy from Berenberg Bank

Unknown AnalystDZ BANK AG

Not Ranked

DZ BANK AG

―

Buy

―

Reiterated

07/28/25

DZ BANK AG Sticks to Its Buy Rating for Qiagen (QGEN)

Aisyah NoorMorgan Stanley

Morgan Stanley

$50.13

Hold

3.66%

Upside

Reiterated

07/25/25

Hold Rating for Qiagen Amid Horizon Europe Funding Prospects

Michael RyskinBank of America Securities

Bank of America Securities

$53

Buy

9.59%

Upside

Reiterated

07/18/25

Qiagen (QGEN) Gets a Buy from Bank of America Securities

Patrick B DonnellyCiti

Citi

$55

Buy

13.73%

Upside

Assigned

05/20/25

Qiagen's Strong Positioning and Growth Potential Earns Buy Rating from Analyst

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

TipRanks AITipRanks

Not Ranked

TipRanks

$52

Hold

7.53%

Upside

Downgraded

08/07/25

Daniel AriasStifel Nicolaus

Stifel Nicolaus

$45

Hold

-6.95%

Downside

Reiterated

08/08/25

Dan LeonardUBS

UBS

$48→$50

Hold

3.39%

Upside

Reiterated

08/07/25

Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (NASDAQ: PRCT), Amgen (NASDAQ: AMGN) and Qiagen (NYSE: QGEN)

Catherine Ramsey SchulteRobert W. Baird

Robert W. Baird

$45→$49

Hold

1.32%

Upside

Reiterated

08/07/25

Robert W. Baird Reaffirms Their Hold Rating on Qiagen (QGEN)

Daniel BrennanTD Cowen

TD Cowen

$49→$52

Hold

7.53%

Upside

Reiterated

08/07/25

TD Cowen Keeps Their Hold Rating on Qiagen (QGEN)

Tycho PetersonJefferies

Jefferies

―

Buy

―

Reiterated

08/07/25

Analysts Conflicted on These Healthcare Names: QuidelOrtho (NASDAQ: QDEL), Qiagen (NYSE: QGEN) and Halozyme (NASDAQ: HALO)

Andrew BrackmannWilliam Blair

William Blair

―

Hold

―

Assigned

08/07/25

Hold Rating on Qiagen Amidst Strong Performance and Market Uncertainties

Luke SergottBarclays

Barclays

$55

Buy

13.73%

Upside

Reiterated

08/07/25

Barclays Sticks to Their Buy Rating for Qiagen (QGEN)

Casey WoodringJ.P. Morgan

J.P. Morgan

$60

Buy

24.07%

Upside

Reiterated

08/06/25

J.P. Morgan Remains a Buy on Qiagen (QGEN)

Jan KochDeutsche Bank

Deutsche Bank

―

Buy

―

Reiterated

08/06/25

Qiagen (QGEN) Gets a Buy from Deutsche Bank

Harry GillisBerenberg Bank

Berenberg Bank

$58.29

Buy

20.54%

Upside

Reiterated

07/31/25

Qiagen (QGEN) Gets a Buy from Berenberg Bank

Unknown AnalystDZ BANK AG

Not Ranked

DZ BANK AG

―

Buy

―

Reiterated

07/28/25

DZ BANK AG Sticks to Its Buy Rating for Qiagen (QGEN)

Aisyah NoorMorgan Stanley

Morgan Stanley

$50.13

Hold

3.66%

Upside

Reiterated

07/25/25

Hold Rating for Qiagen Amid Horizon Europe Funding Prospects

Michael RyskinBank of America Securities

Bank of America Securities

$53

Buy

9.59%

Upside

Reiterated

07/18/25

Qiagen (QGEN) Gets a Buy from Bank of America Securities

Patrick B DonnellyCiti

Citi

$55

Buy

13.73%

Upside

Assigned

05/20/25

Qiagen's Strong Positioning and Growth Potential Earns Buy Rating from Analyst

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Qiagen

1 Month

xxx

Success Rate

8/13 ratings generated profit

Average Return

+1.88%

reiterated a xxx

rating 2 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 61.54% of your transactions generating a profit, with an average return of +1.88% per trade.

3 Months

xxx

Success Rate

11/17 ratings generated profit

Average Return

+2.94%

reiterated a xxx

rating 6 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 64.71% of your transactions generating a profit, with an average return of +2.94% per trade.

1 Year

Tycho PetersonJefferies

Success Rate

11/13 ratings generated profit

Average Return

+14.88%

reiterated a buy rating 2 days ago

Copying Tycho Peterson's trades and holding each position for 1 Year would result in 84.62% of your transactions generating a profit, with an average return of +14.88% per trade.

2 Years

xxx

Success Rate

9/11 ratings generated profit

Average Return

+7.63%

reiterated a xxx

rating 22 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 81.82% of your transactions generating a profit, with an average return of +7.63% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

QGEN Analyst Recommendation Trends

Rating

Apr 25

May 25

Jun 25

Jul 25

Aug 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, QGEN has received 17 Buy Ratings, 10 Hold Ratings, and 0 Sell Ratings. QGEN average Analyst price target in the past 3 months is 52.08.

Each month's total comprises the sum of three months' worth of ratings.

QGEN Financial Forecast

QGEN Earnings Forecast

Next quarter’s earnings estimate for QGEN is $0.59 with a range of $0.58 to $0.60. The previous quarter’s EPS was $0.60. QGEN beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.63% of the time in the same period. In the last calendar year QGEN has Preformed in-line its overall industry.

QGEN Sales Forecast

Next quarter’s sales forecast for QGEN is $525.63M with a range of $523.00M to $527.40M. The previous quarter’s sales results were $533.54M. QGEN beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.66% of the time in the same period. In the last calendar year QGEN has Preformed in-line its overall industry.

QGEN Stock Forecast FAQ

What is QGEN’s average 12-month price target, according to analysts?

Based on analyst ratings, Qiagen’s 12-month average price target is 52.08.

What is QGEN’s upside potential, based on the analysts’ average price target?

Qiagen has 7.69% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is QGEN a Buy, Sell or Hold?

Qiagen has a consensus rating of Moderate Buy which is based on 8 buy ratings, 7 hold ratings and 0 sell ratings.

What is Qiagen’s price target?

The average price target for Qiagen is 52.08. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $60.00 ,the lowest forecast is $45.00. The average price target represents 7.69% Increase from the current price of $48.36.

What do analysts say about Qiagen?

Qiagen’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 15 Wall Streets Analysts.

How can I buy shares of QGEN?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Qiagen (QGEN) Stock Forecast & Price Target

QGEN Analyst Ratings

QGEN Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Qiagen

QGEN Analyst Recommendation Trends

QGEN Financial Forecast

QGEN Earnings Forecast

QGEN Sales Forecast

QGEN Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts